Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis

M-Type Phospholipase A ₂ Receptor as Target Antigen in Idiopathic Membranous Nephropathy

Laurence H. Beck, Ramon Bonegio, Gérard Lambeau et al. · New England Journal of Medicine · 2009 · 2.3K citations · Full text

Medicine, Immunology, Pathology +17

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour et al. · New England Journal of Medicine · 2019 · 600 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin

Karin Schwarz, Matias Simons, Jochen Reiser et al. · Journal of Clinical Investigation · 2001 · 501 citations

Life Sciences, Cell Biology, Molecular Biology +15

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

Medicine, Nephrology, Pediatrics +14

Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology

Journal of the American Society of Nephrology · 2021 · 380 citations · Full text

Life Sciences, Immunology, Nephrology +17